These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32189095)

  • 1. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
    Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
    Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
    Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
    Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
    Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
    J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
    Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
    Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.
    Mallick S; Gandhi AK; Sharma DN; Gupta S; Haresh KP; Rath GK; Julka PK
    Childs Nerv Syst; 2015 Dec; 31(12):2341-4. PubMed ID: 26438548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases.
    Rath GK; Sharma DN; Mallick S; Gandhi AK; Joshi NP; Haresh KP; Gupta S; Julka PK
    Indian J Cancer; 2015; 52(4):599-603. PubMed ID: 26960490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
    Wang X; Jiang J; Liu M; You C
    Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.
    Gupta S; Mallick S; Benson R; Haresh KP; Julka PK; Rath GK
    Childs Nerv Syst; 2017 Jun; 33(6):951-956. PubMed ID: 28424876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
    Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
    Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
    Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.